Holder snapshot 7 signals
Share change
+1,783,553
Put/Call ratio
7.2%
SEC-reported price per share
$41.59
Number of holders
67
Value change
+$80,484,868
Number of buys
35
Open additional details 1 more signal available
Number of sells
30
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
50,565,476

Security key

088786108

Report period

Q3 2021

Institutions

67

Top holders

10

Ownership snapshot

Top reported holders of BCYC - BICYCLE THERAPEUTICS PLC - American Depositary Shares, each representing one ordinary share, nominal value 0.01 euro per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
TYBOURNE CAPITAL MANAGEME...
Disclosed value leader
TYBOURNE CAPITAL MANAGEME...
Comparable rows
0/15
Latest evidence
13 Jul 2021
13F 3/4/5 Highest disclosed value: $59,444,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

TYBOURNE CAPITAL MANAGEMENT (HK) LTD has the largest disclosed position value at $59.44M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens TYBOURNE CAPITAL MANAGEMENT (HK) LTD's linked filing trail.
Disclosed position value Top 5
TYBOURNE CAPITAL MANAGEMENT (HK) LTD $59.44M
SV Health Investors, LLC $58.15M
Janus Henderson Group Ltd. $56.2M
Point72 Asset Management, L.P. $54.83M
EVENTIDE ASSET MANAGEMENT, LLC $35.32M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
TYBOURNE CAPITAL MANAGEMENT (HK) LTD
13F
Company
13F
—
denominator unverified
$59,444,000
1,957,961 shares
— 30 Jun 2021
SV Health Investors, LLC
13F
Company
13F
—
denominator unverified
$58,147,000
1,915,274 shares
— 30 Jun 2021
Janus Henderson Group Ltd.
13F
Company
13F
—
denominator unverified
$56,202,000
1,849,720 shares
— 30 Jun 2021
Point72 Asset Management, L.P.
13F
Company
13F
—
denominator unverified
$54,828,000
1,805,935 shares
— 30 Jun 2021
EVENTIDE ASSET MANAGEMENT, LLC
13F
Company
13F
—
denominator unverified
$35,323,000
1,163,471 shares
— 30 Jun 2021
Kate Bingham
3/4/5
Director
—
denominator unverified
$32,731,633
1,870,379 shares
— 13 Jul 2021
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2021

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
67
Shares
14,210,499
Rows available
67
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2021 vs Q2 2021 Across Filers

Q2 2021 holders
53
Q3 2021 holders
67
Holder diff
14
Investor Q2 2021 Shares Q3 2021 Shares Share Diff Share Chg % Q2 2021 value Q3 2021 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .